166 related articles for article (PubMed ID: 17043637)
1. Urokinase receptor primes cells to proliferate in response to epidermal growth factor.
Jo M; Thomas KS; Takimoto S; Gaultier A; Hsieh EH; Lester RD; Gonias SL
Oncogene; 2007 Apr; 26(18):2585-94. PubMed ID: 17043637
[TBL] [Abstract][Full Text] [Related]
2. Dynamic assembly of the urokinase-type plasminogen activator signaling receptor complex determines the mitogenic activity of urokinase-type plasminogen activator.
Jo M; Thomas KS; Marozkina N; Amin TJ; Silva CM; Parsons SJ; Gonias SL
J Biol Chem; 2005 Apr; 280(17):17449-57. PubMed ID: 15728176
[TBL] [Abstract][Full Text] [Related]
3. EGF receptor transactivation by urokinase receptor stimulus through a mechanism involving Src and matrix metalloproteinases.
Guerrero J; Santibañez JF; González A; Martínez J
Exp Cell Res; 2004 Jan; 292(1):201-8. PubMed ID: 14720519
[TBL] [Abstract][Full Text] [Related]
4. Crosstalk between the urokinase-type plasminogen activator receptor and EGF receptor variant III supports survival and growth of glioblastoma cells.
Hu J; Jo M; Cavenee WK; Furnari F; VandenBerg SR; Gonias SL
Proc Natl Acad Sci U S A; 2011 Sep; 108(38):15984-9. PubMed ID: 21896743
[TBL] [Abstract][Full Text] [Related]
5. Epidermal growth factor receptor-dependent and -independent cell-signaling pathways originating from the urokinase receptor.
Jo M; Thomas KS; O'Donnell DM; Gonias SL
J Biol Chem; 2003 Jan; 278(3):1642-6. PubMed ID: 12426305
[TBL] [Abstract][Full Text] [Related]
6. A switch role of Src in the biphasic EGF signaling of ER-negative breast cancer cells.
Zhang X; Meng J; Wang ZY
PLoS One; 2012; 7(8):e41613. PubMed ID: 22927910
[TBL] [Abstract][Full Text] [Related]
7. Endogenously produced urokinase-type plasminogen activator is a major determinant of the basal level of activated ERK/MAP kinase and prevents apoptosis in MDA-MB-231 breast cancer cells.
Ma Z; Webb DJ; Jo M; Gonias SL
J Cell Sci; 2001 Sep; 114(Pt 18):3387-96. PubMed ID: 11591826
[TBL] [Abstract][Full Text] [Related]
8. Elevated urokinase-specific surface receptor expression is maintained through its interaction with urokinase plasminogen activator.
Mahanivong C; Yu J; Huang S
Mol Carcinog; 2007 Mar; 46(3):165-75. PubMed ID: 17186542
[TBL] [Abstract][Full Text] [Related]
9. A direct link between expression of urokinase plasminogen activator receptor, growth rate and oncogenic transformation in mouse embryonic fibroblasts.
Mazzieri R; Furlan F; D'Alessio S; Zonari E; Talotta F; Verde P; Blasi F
Oncogene; 2007 Feb; 26(5):725-32. PubMed ID: 16878153
[TBL] [Abstract][Full Text] [Related]
10. STAT5b, a Mediator of Synergism between c-Src and the Epidermal Growth Factor Receptor.
Kloth MT; Laughlin KK; Biscardi JS; Boerner JL; Parsons SJ; Silva CM
J Biol Chem; 2003 Jan; 278(3):1671-9. PubMed ID: 12429742
[TBL] [Abstract][Full Text] [Related]
11. Mitogenic signaling of urokinase receptor-deficient kidney fibroblasts: actions of an alternative urokinase receptor and LDL receptor-related protein.
Zhang G; Cai X; López-Guisa JM; Collins SJ; Eddy AA
J Am Soc Nephrol; 2004 Aug; 15(8):2090-102. PubMed ID: 15284295
[TBL] [Abstract][Full Text] [Related]
12. Osteopontin induces AP-1-mediated secretion of urokinase-type plasminogen activator through c-Src-dependent epidermal growth factor receptor transactivation in breast cancer cells.
Das R; Mahabeleshwar GH; Kundu GC
J Biol Chem; 2004 Mar; 279(12):11051-64. PubMed ID: 14704150
[TBL] [Abstract][Full Text] [Related]
13. Epidermal growth factor receptor-mediated regulation of urokinase plasminogen activator expression and glioblastoma invasion via C-SRC/MAPK/AP-1 signaling pathways.
Amos S; Redpath GT; Dipierro CG; Carpenter JE; Hussaini IM
J Neuropathol Exp Neurol; 2010 Jun; 69(6):582-92. PubMed ID: 20467333
[TBL] [Abstract][Full Text] [Related]
14. Epidermal growth factor modulates prostate cancer cell invasiveness regulating urokinase-type plasminogen activator activity. EGF-receptor inhibition may prevent tumor cell dissemination.
Festuccia C; Angelucci A; Gravina GL; Biordi L; Millimaggi D; Muzi P; Vicentini C; Bologna M
Thromb Haemost; 2005 May; 93(5):964-75. PubMed ID: 15886816
[TBL] [Abstract][Full Text] [Related]
15. Protease-mediated human smooth muscle cell proliferation by urokinase requires epidermal growth factor receptor transactivation by triple membrane signaling.
Duru EA; Fu Y; Davies MG
J Surg Res; 2014 Dec; 192(2):254-62. PubMed ID: 25082749
[TBL] [Abstract][Full Text] [Related]
16. Plasminogen activator inhibitor 1 functions as a urokinase response modifier at the level of cell signaling and thereby promotes MCF-7 cell growth.
Webb DJ; Thomas KS; Gonias SL
J Cell Biol; 2001 Feb; 152(4):741-52. PubMed ID: 11266465
[TBL] [Abstract][Full Text] [Related]
17. Dihydrotestosterone potentiates EGF-induced ERK activation by inducing SRC in fetal lung fibroblasts.
Lee MK; Smith SM; Murray S; Pham LD; Minoo P; Nielsen HC
Am J Respir Cell Mol Biol; 2014 Jul; 51(1):114-24. PubMed ID: 24484548
[TBL] [Abstract][Full Text] [Related]
18. Signal transducer and activator of transcription 5b, c-Src, and epidermal growth factor receptor signaling play integral roles in estrogen-stimulated proliferation of estrogen receptor-positive breast cancer cells.
Fox EM; Bernaciak TM; Wen J; Weaver AM; Shupnik MA; Silva CM
Mol Endocrinol; 2008 Aug; 22(8):1781-96. PubMed ID: 18550772
[TBL] [Abstract][Full Text] [Related]
19. D2A sequence of the urokinase receptor induces cell growth through αvβ3 integrin and EGFR.
Eden G; Archinti M; Arnaudova R; Andreotti G; Motta A; Furlan F; Citro V; Cubellis MV; Degryse B
Cell Mol Life Sci; 2018 May; 75(10):1889-1907. PubMed ID: 29184982
[TBL] [Abstract][Full Text] [Related]
20. GEP100 regulates epidermal growth factor-induced MDA-MB-231 breast cancer cell invasion through the activation of Arf6/ERK/uPAR signaling pathway.
Hu Z; Xu R; Liu J; Zhang Y; Du J; Li W; Zhang W; Li Y; Zhu Y; Gu L
Exp Cell Res; 2013 Aug; 319(13):1932-1941. PubMed ID: 23747719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]